Utah Medical Products (UTMD) Competitors $64.18 -0.51 (-0.79%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends UTMD vs. ARAY, CERS, OSUR, ANIK, TELA, SPNE, CTSO, CODX, WST, and COOShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Accuray (ARAY), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), TELA Bio (TELA), SeaSpine (SPNE), Cytosorbents (CTSO), Co-Diagnostics (CODX), West Pharmaceutical Services (WST), and Cooper Companies (COO). These companies are all part of the "medical" sector. Utah Medical Products vs. Accuray Cerus OraSure Technologies Anika Therapeutics TELA Bio SeaSpine Cytosorbents Co-Diagnostics West Pharmaceutical Services Cooper Companies Accuray (NASDAQ:ARAY) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking. Does the media prefer ARAY or UTMD? In the previous week, Accuray had 2 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for Accuray and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.54 beat Accuray's score of 0.43 indicating that Utah Medical Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accuray 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Utah Medical Products 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is ARAY or UTMD more profitable? Utah Medical Products has a net margin of 34.62% compared to Accuray's net margin of -3.72%. Utah Medical Products' return on equity of 12.10% beat Accuray's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-3.72% -36.93% -3.52% Utah Medical Products 34.62%12.10%11.50% Which has more risk & volatility, ARAY or UTMD? Accuray has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Do analysts prefer ARAY or UTMD? Accuray presently has a consensus price target of $9.00, suggesting a potential upside of 391.80%. Given Accuray's stronger consensus rating and higher probable upside, equities research analysts plainly believe Accuray is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor ARAY or UTMD? Accuray received 178 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 65.61% of users gave Accuray an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote. CompanyUnderperformOutperformAccurayOutperform Votes33265.61% Underperform Votes17434.39% Utah Medical ProductsOutperform Votes15461.60% Underperform Votes9638.40% Do institutionals & insiders hold more shares of ARAY or UTMD? 64.1% of Accuray shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 4.2% of Accuray shares are held by insiders. Comparatively, 6.6% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has better valuation & earnings, ARAY or UTMD? Utah Medical Products has lower revenue, but higher earnings than Accuray. Accuray is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$444.20M0.41-$15.55M-$0.17-10.76Utah Medical Products$50.22M4.33$16.64M$4.2715.03 SummaryUtah Medical Products beats Accuray on 10 of the 18 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$219.40M$4.46B$5.05B$8.87BDividend Yield1.86%36.76%4.97%4.06%P/E Ratio15.0314.8997.3414.18Price / Sales4.3347.261,218.4289.42Price / Cash10.2152.2233.5132.79Price / Book1.755.475.805.12Net Income$16.64M$13.76M$119.07M$225.99M7 Day Performance-3.52%-1.08%-1.83%-1.32%1 Month Performance-2.42%0.58%-3.64%0.60%1 Year Performance-23.00%50.91%31.62%26.23% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products3.4454 of 5 stars$64.18-0.8%N/A-23.5%$219.40M$50.22M15.03180Positive NewsARAYAccuray4.6437 of 5 stars$1.83-0.5%$9.00+391.8%-32.5%$185.04M$444.20M-10.76987CERSCerus2.6525 of 5 stars$1.66-1.2%$3.63+118.4%-7.3%$308.29M$176.23M-15.09625Positive NewsOSUROraSure Technologies4.4914 of 5 stars$3.81-1.3%$6.67+75.0%-47.2%$284.19M$405.47M25.40638ANIKAnika Therapeutics2.8624 of 5 stars$17.18+0.8%$24.50+42.6%-16.6%$249.57M$164.17M-2.58357High Trading VolumeTELATELA Bio3.7058 of 5 stars$2.90-0.3%$9.25+219.0%-40.5%$114.62M$58.45M0.00120SPNESeaSpineN/A$9.54flatN/A+0.0%$354.92M$191.45M-5.39523Gap DownCTSOCytosorbents1.2772 of 5 stars$0.92-4.2%$2.00+118.4%-34.6%$52.47M$33.79M-2.54186Analyst ForecastGap DownCODXCo-Diagnostics4.3602 of 5 stars$1.04-2.8%$1.50+44.2%-27.8%$33.21M$6.81M-0.75100Short Interest ↓Gap DownWSTWest Pharmaceutical Services4.9661 of 5 stars$311.67+2.5%$460.33+47.7%-10.7%$22.02B$2.95B46.2410,600Analyst RevisionCOOCooper Companies3.4825 of 5 stars$99.08+0.0%$117.00+18.1%+17.3%$19.73B$3.59B55.2015,000Analyst Downgrade Related Companies and Tools Related Companies Accuray Alternatives Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives TELA Bio Alternatives SeaSpine Alternatives Cytosorbents Alternatives Co-Diagnostics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UTMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
